Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
28.19
+1.53 (5.74%)
At close: May 1, 2026, 4:00 PM EDT
27.75
-0.44 (-1.56%)
After-hours: May 1, 2026, 5:06 PM EDT
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $690.04 million as of May 1, 2026. Its market cap has increased by 1,344.12% in one year.
Market Cap
690.04M
Enterprise Value
613.08M
1-Year Change
1,344.12%
Ranking
Category
Stock Price
$28.19
Market Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has increased from $181.43M to $690.04M, an increase of 280.33%. That is a compound annual growth rate of 25.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 690.04M | 41.91% |
| Dec 31, 2025 | 486.26M | 234.91% |
| Dec 31, 2024 | 145.19M | 386.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Absci | 764.80M |
| Tenax Therapeutics | 752.46M |
| Alpha Tau Medical | 751.60M |
| Vor Biopharma | 750.47M |
| Allogene Therapeutics | 739.55M |
| Gyre Therapeutics | 712.25M |
| Solid Biosciences | 701.69M |
| Lexicon Pharmaceuticals | 690.60M |